Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

TIVDAK is used for the treatment of cervical cancer that has come back after chemotherapy. Chemotherapy is a treatment that uses medicines to stop the growth of cancer cells. This is done either by killing the cells or by stopping them from growing. The purpose of this study is to learn about possible side effects of TIVDAK, specially to any side effect that is related to the eye. A side effect is anything a medicine does to your body that is not part of how the medicine treats disease. * This study is seeking for participants who: Are willing to take all the required eye tests * Have not rec

Trial Details

NCT ID
NCT06952660
Phase
PHASE4
Sponsor
Pfizer
Status
RECRUITING
Cancer Type
Cervical Cancer
Interventions
  • TIVDAK
Locations (sample)
  • Phoenix, Arizona, United States|33.44838,-112.07404
  • Phoenix, Arizona, United States|33.44838,-112.07404
  • Phoenix, Arizona, United States|33.44838,-112.07404
  • Phoenix, Arizona, United States|33.44838,-112.07404
  • Phoenix, Arizona, United States|33.44838,-112.07404

Key Eligibility Criteria

  • Must have recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
  • Treating physician has determined that treatment with Tivdak is appropriate for the participant according to US Prescribing Information
  • Must sign an informed consent form indicating that the participant understands the purpose and procedures required for the study and are willing to…
  • Must be willing to undergo repeated ocular assessments as required by the study and regular clinic visits according to local standard practice of t…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Cervical Cancer Trials on Trialify →